Market Access News | pharmaphorum

News

CDC stops backing COVID jabs for pregnant women, children

In a new sign of downgraded support for COVID-19 shots by the US administration, the CDC has stopped backing vaccines for pregnant women and children.

News

Autolus closes on EU okay for leukaemia cell therapy

The CHMP backed approval of Autolus' leukaemia CAR-T Aucatzyl, as well as drugs from GSK, Roche, SpringWorks, and others, at its May meeting.

News

NICE relents and backs drug for IgAN from CSL Vifor

Thousands of people living with rare kidney disease IgAN in the UK will soon be able to access a new oral treatment from CSL Vifor.

News

GSK claims first approval for Nucala in COPD

GSK gets FDA approval for Nucala in COPD, setting up a marketing tussle with Sanofi/Regeneron's Dupixent.

News

Pfizer's weekly haemophilia drug backed for NHS use

Some patients in England living with severe haemophilia B will soon be able to do away with need for regular infusions.

News

FDA tightens heart tox warnings on mRNA COVID vaccines

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity.

CDC stops backing COVID jabs for pregnant women, children

Autolus closes on EU okay for leukaemia cell therapy

NICE relents and backs drug for IgAN from CSL Vifor

GSK claims first approval for Nucala in COPD

Pfizer's weekly haemophilia drug backed for NHS use

FDA tightens heart tox warnings on mRNA COVID vaccines

Trump sets course for 100%, then 200%, tariffs on generics

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks